Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
Développer la qualité dans le champ sanitaire, social et médico-social
Logo
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. BRAFTOVI (encorafenib)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • Établissements de santé
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

BRAFTOVI (encorafenib)

Medicine - Posted on Oct 02 2026
Active substance (DCI)
  • encorafenib
history (2)
  • 9/23/26

    BRAFTOVI (encorafenib) - cancer colorectal métastatique

    Autorisation d’accès précoce octroyée à la spécialité BRAFTOVI (encorafenib) dans l'indication « en association avec le cetu...
    icône flèche
  • Economic analysis
    12/16/20

    BRAFTOVI (encorafenib)

    Key points Favourable opinion for reimbursement in the treatment of adult patients with metastatic colorectal cancer with a ...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • L01XE46
Manufacturer
PIERRE FABRE MEDICAMENT
Presentation

BRAFTOVI 75 mg, gélule - 7 plaquettes polyamide aluminium PVC de 6 gélules (CIP : 34009 301 568 5 8)

All our publications
    Digestive system cancers Drug therapy

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
eNq1mF1v2jAUhu/5FVHuSRoo/ZgC1cbaDanVGC3atJvKSU6KWWqnxzbQ/fo5hK4wOWpr6juInfec+Lx+fOT4bHVfeAtAQTnr+1Fw4HvAUp5Rdtf3pzcX7RP/bNCK52RBnqd19LwginwvLYgQfb8aDRIgTAQ/ry4/g34f0B+0vJgnc0jlzjwlaRF8JWJ2RcpqjhcvOM28e5AznvX9Usn1Uy8WEnUWgyXH36IkKcTh5sn26Pz2cPt5HFZir1BVAvCSsDujKDArzVQhApNDIuGO42NDvl0rbSomILjCFMZEzsbIFzSDzBgiJ4UAqyD5MrsGXBQgqyBG8XCe3gsrcTInqwk8jMxJf9SjQ7mS7YN2dHwaHXcPT3tHnd6BVSjcWipzFfRHhOVtt9PpHfU6IbAwQZJLvajtyv36NzCaWBZqzFGSwlGJqBjuusxRHISHF62QUVEW5DGYi9J2qQgSPQyoWeDuQ6ovuEFNp0Kv2X/6TBVF+Maspxt2OMq4QtOQKyYbEHIxsV2IIWcSVs0VtaOeXG28SEG8n+wfzszEH6ukoKkt3zSBFAg5nYya8eaMDJ+IgCm6Q8MPyjK+FO+PnO0SO8q+XFPTKFpiFt12Tk+Ool7Pekf90n5qOHvOFfISQg0jKvZhzIjlfF+6aIuapZ4M6sab63aIp6SAhoaobUkdbcqn/s2Z7d1tqXrAKPrl/MbWK98V4OP1+q9Rmmb9f1W2Q7ILzmtnNib+dp/X291Jq6zQjJGZlKX4EIYzItqC6BUKcnTL+63z1l3H7uRQr5ucmpmOUk/qw/D1pbLdbi8d+fu2sZv3N+2yMYZEBXvUoSazM36Ozt8fyc89rLO0xzsIcRdm3W8SSTlz1fqoxNz37HUI6LqyC9Rw+JbntOH2pNGXcVjf3AxacVjd2gxafwH1jfYh
JBHckRNbxT9Vpa5z